Recent news
January 2011
Incentives to spur global health research and delivery are working, blog says
January 7, 2011 -- This week, the pneumococcal vaccine was introduced in Nicaragua—the “first vaccine delivered as a direct result of a novel market-based incentive for global health: the Advance Market Commitment (AMC),” J. Leighton Read of Alloy Ventures who also served on the board of BIO Ventures for Global Health, writes in a blog post. He adds that next year “should be a really great year. Rwanda and Gambia are set for introduction and vaccine has already shipped to Sierra Leone, Honduras, Guyana, Yemen, and Kenya.”
According to Read, the AMC played a huge part in these successes because it helps create a “return on investment where market pull is otherwise insufficient.” He adds, “In an environment where donors often find it compelling to pick their own favorite approaches with ‘push’ funding, it is refreshing to see new market-based solutions succeed by ‘pulling’ successful innovation through the pipeline all the way to the people who need our help the most. I hope that 2011 will see commitments to another market-based solution for global health. They work.” See the link below for more details.
